Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;31(1):73-82.
doi: 10.1007/s10792-010-9397-5. Epub 2010 Sep 23.

Prevention of age-related macular degeneration

Affiliations
Review

Prevention of age-related macular degeneration

Ian Yat Hin Wong et al. Int Ophthalmol. 2011 Feb.

Abstract

Age-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most cost-effective management of AMD is to start with prevention. This review looks at current evidence on preventive measures targeted at AMD. Modalities reviewed include (1) nutritional supplements such as the Age-Related Eye Disease Study (AREDS) formula, lutein and zeaxanthin, omega-3 fatty acid, and berry extracts, (2) lifestyle modifications, including smoking and body-mass-index, and (3) filtering sunlight, i.e. sunglasses and blue-blocking intraocular lenses. In summary, the only proven effective preventive measures are stopping smoking and the AREDS formula.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eye Disease Prevalence Research Group Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572. doi: 10.1001/archopht.122.4.564. - DOI - PubMed
    1. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol. 1996;80:9–14. doi: 10.1136/bjo.80.1.9. - DOI - PMC - PubMed
    1. VanNewkirk M, Weih LM, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the visual impairment project. Ophthalmology. 2001;108:960–967. doi: 10.1016/S0161-6420(01)00554-1. - DOI - PubMed
    1. Bressler NM. Age related macular degeneration. New hope for a common problem comes from photodynamic therapy. BMJ. 2000;321:1425–1427. doi: 10.1136/bmj.321.7274.1425. - DOI - PMC - PubMed
    1. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598–614. doi: 10.1001/archopht.122.4.598. - DOI - PubMed